Safety and Efficacy Evaluation of the Mosaic Ultra Device

Eligibility Criteria

• * Non-smoking, Male or Female
• * Age 18 - 60 years old
• * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated.
• * Participants who are willing and able to comply with all study participation requirements including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.
• * OPTIONAL - Participants who are willing to undergo biopsies.
• * Previous surgical or cosmetic procedure to the target area in the last 6 to 12 months that could interfere with the treatment procedure
• * A study participant must not be pregnant or have been pregnant in the last 3 months
• * A recent history of smoking (6 months)
• * Presence of an active skin disease or condition that may affect wound healing (ie. diabetes myelitis; connective tissue disease; radiation therapy; or chemotherapy)
• * Seizure disorder caused by bright light
• * A history of thrombophlebitis
• * A history of acute infections
• * A history of heart failure
• * Cancer, malignant disease, skin pathology, condition, or allergic reactions that could interfere with evaluation or with the use of typical ancillary medical treatments or care used before, during, or after treatments
• * Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics, vitamin E, or anti-inflammatories within 2 weeks prior to treatment
• * Intolerance or allergy to medications that could be prescribed before or after the procedure (eg, antibiotics, anesthesia)
• * A history of keloids
• * A history or evidence of poor wound healing
• * A history of coagulative disorder or current use of anticoagulant drugs within 2 weeks of study participation
• * Use of steroids within 2 weeks of study treatments
• * Patients with implanted pacemaker or defibrillator, or metal pins, or prosthetic joints within 4 cm of treatment area
• * History of psychoneurosis and/or a history of alcohol or drug abuse